These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Comparison of the benefits and risks in the treatment of chronic juvenile arthritis with gold salts].
    Author: Mesihović H, Trebinjac S, Mesihović S, Buljina A.
    Journal: Lijec Vjesn; 1991; 113(11-12):420-2. PubMed ID: 1669615.
    Abstract:
    Benefits and risks of gold therapy in patients with juvenile chronic arthritis (JCA) were reviewed. An improvement of laboratory and clinical parameters was observed in eight out of the 16 children of the sample (10 boys and 6 girls). The side effects were noticed in 5 patients, but only in one of these children gold therapy had to be stopped due to alopecia areata. Corticosteroid dose was significantly reduced in 7 out of the 11 patients. It is concluded that gold salts may be effectively applied as primary therapy in children with JCA, with no more risk than in adults.
    [Abstract] [Full Text] [Related] [New Search]